HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BI 2536

polo-like kinase 1 inhibitor
Networked: 43 relevant articles (2 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Munzert, Gerd: 8 articles (04/2013 - 12/2008)
2. Fritsch, Holger: 6 articles (04/2013 - 07/2010)
3. Brassesco, María Sol: 3 articles (07/2013 - 05/2012)
4. Trommeshauser, Dirk: 3 articles (09/2010 - 12/2008)
5. Raab, Monika: 2 articles (01/2015 - 05/2014)
6. Sanhaji, Mourad: 2 articles (01/2015 - 02/2012)
7. Strebhardt, Klaus: 2 articles (01/2015 - 05/2014)
8. Becker, Sven: 2 articles (01/2015 - 05/2014)
9. Dissous, Colette: 2 articles (06/2014 - 06/2011)
10. Ambudkar, Suresh V: 2 articles (10/2013 - 01/2013)

Related Diseases

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
2. Hepatocellular Carcinoma (Hepatoma)
3. Neoplasms (Cancer)
4. Breast Neoplasms (Breast Cancer)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Messenger RNA (mRNA)
2. polo-like kinase 1
3. Phosphotransferases (Kinase)
4. BI 6727
5. Small Interfering RNA (siRNA)
6. pemetrexed (MTA)
7. 5- (5,6- dimethoxy- 1H- benzimidazol- 1- yl)- 3- ((2- (trifluoromethyl)benzyl)oxy)thiophene- 2- carboxamide
8. Histone Deacetylase Inhibitors
9. Cyclosporine (Ciclosporin)
10. Vincristine (Oncovin)

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Heterologous Transplantation (Xenotransplantation)
3. Drug Therapy (Chemotherapy)